20333-96-4

Upstream product

• 590-92-1 3-Bromopropionic acid 
• 111-92-2 dibutylamine 
• 53280-20-9 methyl 3-dibutylaminopropionate 
• 124-38-9 carbon dioxide 
• 107-21-1 ethylene glycol 
• 67-56-1 methanol 
• 79-10-7 acrylic acid 
• 109-65-9 1-bromo-butane 
• 107-95-9 3-amino propanoic acid 
• 92-84-2 10H-phenothiazine 

Relevant academic research and scientific papers

Carboxylate-assisted formation of alkylcarbonate species from co 2 and tetramethylammonium salts with a β-amino acid anion

Tetramethylammonium-based molten salts bearing a β-amino acid anion (TMAAs) are synthesized through Michael addition reactions of amines with methyl acrylate followed by hydrolysis and subsequent neutralization by using aqueous tetramethylammonium hydroxide. The CO2 capture performances of the TMAAs are evaluated and are shown to interact with CO2 in a 1:1 mode in both water and alcohol. FTIR and 13C NMR spectroscopic studies on the interactions of TMAAs with CO2 indicate that the type of CO 2 adduct varies with the solvent used. When water is used as the solvent, a bicarbonate species is produced, whereas hydroxyethylcarbonate and methylcarbonate species are generated in ethylene glycol and methanol, respectively. Computational calculations show that the carboxylate groups of TMAAs contribute towards the formation and stabilization of 1:1 CO2 adducts through hydrogen bonding interactions with the hydrogen atoms of the amino groups.

QUATERNARY AND CATIONIC AMMONIUM SURFACTANTS AS CORROSION INHIBITORS

Disclosed herein are corrosion inhibiting compounds and compositions useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed herein are methods of using the compounds and compositions as corrosion inhibitors, particularly in applications relating to the production, transportation, storage, and separation of crude oil and natural gas.

COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION

Disclosed and claimed is a composition and method of inhibiting the formation of hydrate agglomerates in a fluid comprising water, gas, and optionally liquid hydrocarbon. The composition comprises the following formula and the method comprises adding to the fluid an effective anti-agglomerant amount of any of the following formula and optionally salts thereof. R1, R2, and R3 are each independently CnH2n+1 or benzyl. R4 is C4-C20 alkyl or alkenyl. n is an integer from 0 to 10. X? is a counterion.

Selective N -alkylation of β-alanine facilitates the synthesis of a poly(amino acid)-based theranostic nanoagent

The development of functional amino acid-based polymeric materials is emerging as a platform to create biodegradable and nontoxic nanomaterials for medical and biotechnology applications. In particular, facile synthetic routes for these polymers and their corresponding polymeric nanomaterials would have a positive impact in the development of novel biomaterials and nanoparticles. However, progress has been hampered by the need to use complex protection-deprotection methods and toxic phase transfer catalysts. In this study, we report a facile, single-step approach for the synthesis of an N-alkylated amino acid as an AB-type functional monomer to generate a novel pseudo-poly(amino acid), without using the laborious multistep, protection-deprotection methods. This synthetic strategy is reproducible, easy to scale up, and does not produce toxic byproducts. In addition, the synthesized amino acid-based polymer is different from conventional linear polymers as the butyl pendants enhance its solubility in common organic solvents and facilitate the creation of hydrophobic nanocavities for the effective encapsulation of hydrophobic cargos upon nanoparticle formation. Within the nanoparticles, we have encapsulated a hydrophobic DiI dye and a therapeutic drug, Taxol. In addition, we have conjugated folic acid as a folate receptor-targeting ligand for the targeted delivery of the nanoparticles to cancer cells expressing the folate receptor. Cell cytotoxicity studies confirm the low toxicity of the polymeric nanoparticles, and drug-release experiments with the Taxol-encapsulated nanoparticles only exhibit cytotoxicity upon internalization into cancer cells expressing the folate receptor. Taken together, these results suggested that our synthetic strategy can be useful for the one-step synthesis of amino acid-based small molecules, biopolymers, and theranostic polymeric nanoagents for the targeted detection and treatment of cancer.

Betaine compound and process for production thereof

This invention provides a hydroxyl group-containing betaine compound and a long-chain alkyl group-containing betaine compound, both of which are highly biodegradable and useful as surfactants, bactericides, antistatic agents, softening agents, rust inhibitors, resin modifiers, synthetic intermediates, etc. The invention further provides processes for producing such betaine compounds. The hydroxyl group-containing betaine compound mentioned above can be represented by the following general formula (1) wherein R1and R2maybe the same or different and each represents a hydrogen atom, a C1-8hydrocarbon group or a C1-8hydrocarbon group having a hydroxyl group, exclusive of the case in which both of R1and R2respectively represent a hydrogen atom; in case neither R1nor R2represents a hydrogen atom, R1and R2may be joined to each other through a single bond or through at least one kind of element selected from the group consisting of O, S and N; R3represents a hydrogen atom, a methyl group or a hydroxymethyl group; A represents a hydrocarbon group of 2?25 carbon atoms.